Research progress on the mechanism of endocrine therapy resistance for breast cancer / 国际肿瘤学杂志
Journal of International Oncology
;
(12): 352-356, 2023.
Artículo
en Chino
| WPRIM
| ID: wpr-989570
ABSTRACT
Endocrine therapy resistance is a major challenge in the treatment of hormone receptor-positive breast cancer. In recent years, endocrine resistance mechanisms have focused on ESR1 mutations or fusions, epigenetic regulation, abnormal regulation of signal transduction pathway, cell cycle regulation, cancer stem cells, metabolic reprogramming, tumor microenvironment and autophagy. Exploring the latest advances in the mechanisms of endocrine therapy resistance in breast cancer may provide more research ideas and treatment options for the precision treatment of hormone receptor-positive breast cancer.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Journal of International Oncology
Año:
2023
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS